Agathisflavone Modulates the Kynurenine Pathway and Glial Inflammatory Responses with Implications for Neuroprotection
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262411951 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Deivison Silva Argolo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Neurochemistry and Cellular Biology, Department of Biochemistry and Biophysics, Institute of Health Sciences, Federal University of Bah…. Hauptthemen laut MEDLINE: Kynurenine, Biflavonoids, Neuroprotective Agents, Neuroglia. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado da Bahia, National Council for Scientific and Technological Development.
Abstract (Originalsprache)
The cells in the central nervous system (CNS) can adapt to injury and inflammation through structural and functional changes, many of which are mediated by the kynurenine pathway (KP). Studies using glia–neuron co-cultures showed that the biflavonoid agathisflavone (FAB), purified from the leaves of Cenostigma pyramidale Tul., a plant native to the Brazilian caatinga, exerts strong neuroprotective effects. This study evaluated whether agathisflavone (1 µM) modulates these responses in human and murine astrocytes and microglia exposed to inflammatory activation with lipopolysaccharide (LPS, 1 µg/mL), excitotoxic activation of NMDA receptors with quinolinic acid (QUIN, 500 µM), or inhibition of the KP rate-limiting enzyme indoleamine 2,3-dioxygenase 1 (IDO1) with 1-methyl tryptophan (1-MT, 1.5 μM). Co-treatment with FAB increased astrocyte viability relative to LPS, QUIN, or 1-MT alone, by up to 35% (p < 0.05), while reducing GFAP overexpression and other features of reactive astrogliosis. FAB decreased the proportion of Iba-1+ microglia, indicating anti-inflammatory effects. When combined with QUIN or 1-MT, FAB reversed the elevation of iNOS (p < 0.0001) and reduced IL1β upregulation. FAB also modulated KP activity in a cell type-specific manner. In astrocytes, FAB with QUIN or with 1-MT increased IDO activity, whereas in microglia, FAB alone reduced it. In microglia, kynurenine-3-monooxygenase (KMO) expression was significantly increased under FAB+QUIN or FAB+1-MT (p < 0.0001). Finally, astrocyte-conditioned medium from FAB-treated cells increased the viability of neuron-like PC12 cells by up to 40%. Collectively, these findings show that FAB confers cytoprotective and anti-inflammatory actions on glial cells, modulates KP signalling in a context-dependent manner, and supports neuronal survival under neuroinflammatory conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neurochemistry and Cellular Biology, Department of Biochemistry and Biophysics, Institute of Health Sciences, Federal University of Bahia, Av. Reitor Miguel Calmon S/N, Salvador 40231-300, BA, Brazil.
- Center of Biotechnology and Cell Therapy, São Rafael Hospital, D'Or Institute for Research and Education (IDOR), Av. São Rafael, 2152-São Rafael, Salvador 41253-190, BA, Brazil.
- Neuroendocrine Pharmacology Lab, Department of Biological Sciences, Faculty of Science and Engineering, University of Limerick, V94 T9PX Limerick, Ireland.
- School of Medicine, Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2UP, UK.
- Department of General and Inorganic Chemistry, Institute of Chemistry, University Federal da Bahia, Salvador 40170-110, BA, Brazil.
- Laboratory of Phytochemistry, Department of Health, State University of Feira de Santana, Av. Transnordestina, s/n, Feira de Santana 44036-900, BA, Brazil.
ORCID-Profile: Deivison Silva Argolo, Lucas Matheus Gonçalves Oliveira, Cleonice Creusa Dos Santos, Lilian Vanessa da Penha Gonçalves, Erick Correia Loiola, Arthur Morgan Butt, Jorge Mauricio David, Isabella Mary Alves Reis, Silvia Lima Costa, Maria de Fátima Dias Costa
Förderung
- Fundação de Amparo à Pesquisa do Estado da Bahia
- National Council for Scientific and Technological Development
Zitieren
APA
Argolo, D. S., Oliveira, L. M. G., Santos, C. C. D., da Penha Gonçalves, L. V., Loiola, E. C., de Freitas Souza, B. S., Barreto, G. E., Butt, A. M., David, J. M., Branco, A., Reis, I. M. A., Azevedo-Silva, A., Costa, S. L., & Costa, M. F. D. (2025). Agathisflavone Modulates the Kynurenine Pathway and Glial Inflammatory Responses with Implications for Neuroprotection. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262411951
Vancouver
Argolo DS, Oliveira LMG, Santos CCD, da Penha Gonçalves LV, Loiola EC, de Freitas Souza BS, et al. Agathisflavone Modulates the Kynurenine Pathway and Glial Inflammatory Responses with Implications for Neuroprotection. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262411951
BibTeX
@article{Argolo2025,
author = {Argolo, Deivison Silva and Oliveira, Lucas Matheus Gonçalves and Santos, Cleonice Creusa Dos and da Penha Gonçalves, Lilian Vanessa and Loiola, Erick Correia and de Freitas Souza, Bruno Solano and Barreto, George E and Butt, Arthur Morgan and David, Jorge Mauricio and Branco, Alexsandro and Reis, Isabella Mary Alves and Azevedo-Silva, Annabel and Costa, Silvia Lima and Costa, Maria de Fátima Dias},
title = {Agathisflavone Modulates the Kynurenine Pathway and Glial Inflammatory Responses with Implications for Neuroprotection},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262411951}
}
EUVIMED